Mesenchymal Stem Cells and Asthma

Mesenchymal stem cells (MSC) are a type of adult stem cell that can be found in many tissues throughout the body, including the bone marrow, adipose tissue, and even cord blood. MSC have the ability to self-renew and differentiate into a number of different cell types, making them a powerful tool in the regenerative medicine arena. MSC have been shown to be effective in the treatment of a number of diseases and conditions, including asthma. In a study published in the Journal of Allergy and Clinical Immunology, MSC were shown to reduce airway inflammation and improve lung function in a mouse model of asthma. The authors of the study believe that the MSC works by producing anti-inflammatory cytokines and by modulating the immune response. MSC has also been studied in a number of other inflammatory diseases, such as Crohn's disease, rheumatoid arthritis, and multiple sclerosis. In each of these diseases, MSC has been shown to reduce inflammation and improve the function of the affected organ. The use of MSC in the treatment of asthma is still in the early stages of research, but the results so far are promising. MSC offers a novel approach to the treatment of asthma and other inflammatory diseases, and their use may someday lead to more effective and less invasive treatments for these conditions.

 "Unraveling the therapeutic effects of mesenchymal stem cells in ...." 15 Sep. 2020, Accessed 24 Oct. 2022.

 "Mesenchymal Stem Cells Suppress Severe Asthma by ... - NCBI." Accessed 24 Oct. 2022.

 "Mesenchymal Stem Cells Suppress Severe Asthma by ... - PubMed." 31 Aug. 2021, Accessed 24 Oct. 2022.


The information below is the recommended stem cell therapy protocol for this condition 

Route of AdministrationDoseTime (Days)Total Cells
Myers cocktail/NAD50,000,0001N/A
Possibly Inhalational